The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor

被引:92
作者
Atfi, Azeddine
Dumont, Emmanuelle
Colland, Frederic
Bonnier, Dominique
L'Helgoualc'h, Annie
Prunier, Celine
Ferrand, Nathalie
Clement, Bruno
Wewer, Ulla M.
Theret, Nathalie [1 ]
机构
[1] Hop St Antoine, Inst Natl Sante Rech Med, Unit 673, F-75571 Paris, France
[2] Univ Rennes 1, Inst Fed Rech 140, Inst Natl Sante Rech Med, Unit 620, F-35043 Rennes, France
[3] Univ Copenhagen, Innovat Ctr, Dept Biomed & Biotech Res, DK-1017 Copenhagen, Denmark
关键词
D O I
10.1083/jcb.200612046
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transforming growth factor-beta (TGF-beta) regulates a wide variety of biological processes through two types of Ser/Thr transmembrane receptors: the TGF-beta type I receptor and the TGF-beta type 11 receptor (T beta RII). Upon ligand binding, TGF-beta type I receptor activated by T beta RII propagates signals to Smad proteins, which mediate the activation of TGF-beta target genes. In this study, we identify ADAM12 (a disintegrin and metalloproteinase 12) as a component of the TGF-beta signaling pathway that acts through association with T beta RII. We found that ADAM12 functions by a mechanism independent of its protease activity to facilitate the activation of TGF-beta signaling, including the phosphorylation of Smad2, association of Smad2 with Smad4, and transcriptional activation. Furthermore, ADAM12 induces the accumulation of T beta RII in early endosomal vesicles and stabilizes the T beta RII protein presumably by suppressing the association of T beta RII with Smad7. These results define ADAM12 as a new partner of T beta RII that facilitates its trafficking to early endosomes in which activation of the Smad pathway is initiated.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 26 条
[1]   Functional proteomics mapping of a human signaling pathway [J].
Colland, F ;
Jacq, X ;
Trouplin, V ;
Mougin, C ;
Groizeleau, C ;
Hamburger, A ;
Meil, A ;
Wojcik, J ;
Legrain, P ;
Gauthier, JM .
GENOME RESEARCH, 2004, 14 (07) :1324-1332
[2]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[3]   Distinct endocytic pathways regulate TGF-β receptor signalling and turnover [J].
Di Guglielmo, GM ;
Le Roy, C ;
Goodfellow, AF ;
Wrana, JL .
NATURE CELL BIOLOGY, 2003, 5 (05) :410-421
[4]  
Duffy MJ, 2003, THROMB HAEMOSTASIS, V89, P622
[5]   Evidence for a role of Smad3 and Smad2 in stabilization of the tumor-derived mutant Smad2.Q407R [J].
Dumont, E ;
Lallemand, F ;
Prunier, C ;
Ferrand, N ;
Guillouzo, A ;
Clément, B ;
Atfi, A ;
Théret, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (27) :24881-24887
[6]   Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation [J].
Ebisawa, T ;
Fukuchi, M ;
Murakami, G ;
Chiba, T ;
Tanaka, K ;
Imamura, T ;
Miyazono, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12477-12480
[7]   Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, α-actinin-2, is required for myoblast fusion [J].
Galliano, MF ;
Huet, C ;
Frygelius, J ;
Polgren, A ;
Wewer, UM ;
Engvall, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) :13933-13939
[8]   A novel, secreted form of human ADAM 12 (meltrin α) provokes myogenesis in vivo [J].
Gilpin, BJ ;
Loechel, F ;
Mattei, MG ;
Engvall, E ;
Albrechtsen, R ;
Wewer, UM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :157-166
[9]   TGFβ receptor internalization into EEA1-enriched early endosomes:: role in signaling to Smad2 [J].
Hayes, S ;
Chawla, A ;
Corvera, S .
JOURNAL OF CELL BIOLOGY, 2002, 158 (07) :1239-1249
[10]   Trafficking of human ADAM 12-L:: Retention in the trans-Golgi network [J].
Hougaard, S ;
Loechel, F ;
Xu, XF ;
Tajima, R ;
Albrechtsen, R ;
Wewer, UM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) :261-267